| Product Name | FAT1 Antibody |
|---|---|
| Description | Rabbit polyclonal antibody to FAT1 |
| Synonyms | Cadherin family member 7 antibody; Cadherin family member 7 precursor antibody; Cadherin ME5 antibody; Cadherin related tumor suppressor antibody; Cadherin related tumor suppressor homolog antibody; Cadherin related tumor suppressor homolog precursor antibody; Cadherin related tumor suppressor homolog precursor (FAT protein homolog) antibody; Cadherin-related tumor suppressor homolog antibody; CDHF 7 antibody; CDHF7 antibody; FAT 1 antibody; FAT tumor suppressor 1 antibody; FAT tumor suppressor homolog 1 antibody; FAT1 antibody; FAT1_HUMAN antibody; hFat 1 antibody; hFAT antibody; hFat1 antibody; Homolog of Drosophila FAT protein antibody; Homolog of Drosophila FAT protein precursor antibody; Homolog of Drosophila tumor suppressor FAT precursor antibody; ME 5 antibody; ME5 antibody; nuclear form antibody; Protein fat homolog antibody; Protocadherin Fat 1 antibody |
| Host | Rabbit |
| Clonality | Polyclonal |
| Conjugate | Unconjugated |
| Immunogen | Synthetic peptide of human FAT1 |
| Isotype | IgG |
| Target | FAT1 |
| Reactivity | Human |
| Applications | ELISA, IHC |
| Form | Liquid |
| Diluent Buffer | -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol |
| Uniprot | Q14517 |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
| Background | This gene is an ortholog of the Drosophila fat gene, which encodes a tumor suppressor essential for controlling cell proliferation during Drosophila development. The gene product is a member of the cadherin superfamily, a group of integral membrane proteins characterized by the presence of cadherin-type repeats. In addition to containing 34 tandem cadherin-type repeats, the gene product has five epidermal growth factor (EGF)-like repeats and one laminin A-G domain. This gene is expressed at high levels in a number of fetal epithelia. Its product probably functions as an adhesion molecule and/or signaling receptor, and is likely to be important in developmental processes and cell communication. Transcript variants derived from alternative splicing and/or alternative promoter usage exist, but they have not been fully described. |
| Supplier | Cusabio |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
